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Abstract
Background: Succinate is a kind of industrially important C4 platform chemical for synthesis of high value added
products. Due to the economical and environmental advantages, considerable efforts on metabolic engineering
and synthetic biology have been invested for bio-based production of succinate. Precursor phosphoenolpyruvate (PEP) is
consumed for transport and phosphorylation of glucose, and large amounts of byproducts are produced, which are the
crucial obstacles preventing the improvement of succinate production. In this study, instead of deleting genes involved
in the formation of lactate, acetate and formate, we optimized the central carbon metabolism by targeting at metabolic
node PEP to improve succinate production and decrease accumulation of byproducts in engineered E. coli.
Results: By deleting ptsG, ppc, pykA, maeA and maeB, we constructed the initial succinate-producing strain to achieve
succinate yield of 0.22 mol/mol glucose, which was 2.1-fold higher than that of the parent strain. Then, by targeting at
both reductive TCA arm and PEP carboxylation, we deleted sdh and co-overexpressed pck and ecaA, which led to a
significant improvement in succinate yield of 1.13 mol/mol glucose. After fine-tuning of pykF expression by anti-pykF
sRNA, yields of lactate and acetate were decreased by 43.48 and 38.09 %, respectively. The anaerobic stoichiometric
model on metabolic network showed that the carbon fraction to succinate of engineered strains was significantly
increased at the expense of decreased fluxes to lactate and acetate. In batch fermentation, the optimized strain BKS15
produced succinate with specific productivity of 5.89 mmol gDCW−1 h−1.
Conclusions: This report successfully optimizes succinate production by targeting at PEP of the central carbon
metabolism. Co-overexpressing pck-ecaA, deleting sdh and finely tuning pykF expression are efficient strategies for
improving succinate production and minimizing accumulation of lactate and acetate in metabolically engineered E. coli.
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Background
Succinate, an important member of C4-dicarboxylic acid
family, has been widely used in agricultural, food, pharma-
ceutical, cosmetic, textile and fine chemicals industries
[1, 2]. Meanwhile, succinate has received considerable
attention to synthesize various valuable molecules such
as 1,4-butanediol, tetrahydrofuran, γ-butyrolactone and
adipic acid [3]. Petrochemistry-based succinate produc-
tion requires various metal catalysts and discharges
organic wastes, which make petrochemical processes costly
and not environmental friendly. Bio-based succinate pro-
duction is a promising and green process as it uses renew-
able bioresources as substrates and fixes greenhouse gas
CO2 [4]. Therefore, the concomitant economical and en-
vironmental advantages stimulate the efforts to engineer
microorganisms for efficient succinate production.
Succinate can be naturally produced by many strict
anaerobic bacteria and facultative anaerobes. Escherichia
coli is most widely studied for succinate production due
to its convenience for genetic manipulation and fast
growth with flexible nutrient requirements [5]. However,
the wild E. coli strain prefers to produce lactate and acet-
ate as major products with a small amount of succinate in
mixed-acid fermentation under anaerobic conditions [6].
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Efforts of metabolic engineering and adaptive evolution
have been made to obtain succinate-producing E. coli. In-
activation of genes accounting for biosyntheses of those
byproducts was first pursued to produce succinate as the
predominant fermentation product. However, the mutant
E. coli strains deficient in ldhA (coding lactate dehydro-
genase) and pflB (coding pyruvate-formate lyase), adhE
(coding alcohol dehydrogenase) and pta (coding phospho-
transacetylase) or their combinations were unable to an-
aerobically grow on glucose media and the titer and yield
of succinate were relatively low. For example, the mutant
E.coli strain NZN111 deficient in ldhA and pflB only pro-
duced minor amount of succinate [7]. Evolutionary engin-
eering of strain NZN111 led to spontaneous chromosomal
mutant strain AFP111, which was able to ferment glucose
anaerobically and produced higher succinate yield, as well
as higher acetate [8]. Similarly, by combining metabolic en-
gineering and evolution of over 2000 generations screened
on glucose minimal medium, E. coli strain KJ073 with dele-
tions of ldhA, adhE, ackA (coding acetate kinase), focA
(coding formate channel), pflB, mgsA (coding methylglyoxal
synthase) and poxB (coding pyruvate oxidase) was capable
of producing high succinate yield, but significant amounts
of acetate and malate were also produced [9].
Metabolic targets of the central carbon metabolism have
been used to improve succinate production in E. coli. In
order to enhance carbon flux to succinate, formation of
oxaloacetate (OAA) from pyruvate or phosphoenolpyr-
uvate (PEP) was chosen as metabolic target. Heterologous
expressions of pyc (coding pyruvate carboyxlase, PYC)
from Rhizobium etli [10] or from Lactococcus lactis [11,
12], pck (coding PEP carboxykinase, PCK) from Actinoba-
cillus succinogenes [13, 14] and overexpression of native
ppc (coding PEP carboxylase, PPC) [15] were shown to in-
crease succinate production in recombinant E. coli strains.
Subtle co-overexpression of both ppc and pck genes regu-
lated by promoters with different strengths improved
succinate production [16]. To increase NADH availability
in succinate-producing E. coli, several genes involved in
redox reactions were identified to improve cell growth im-
pairment under microaerobic conditions [17]. Heterologous
NAD+-dependent formate dehydrogenase gene fdh of Can-
dida boidinii or native nicotinate phosphoribosyltransferase
gene pncB were co-overexpressed with Lactococcus lactis
pyc gene to achieve the redox and ATP balance [18, 19].
Activation of pentose phosphate pathway, transhydrogenase
and pyruvate dehydrogenase were identified for improved
succinate production by increasing reducing power supple-
ment [20]. To enhance glucose utilization in E. coli strain
deficient in PEP carbohydrate phosphotransferase system
(PTS), native galP (coding D-galactose transporter) and glk
(coding glucokinase) were co-overexpressed or modulated
to facilitate succinate production [21]. Zymomonas mobilis
glf gene (coding glucose facilitator, Glf) was more efficient
than E. coli galP gene due to the higher transport velocity
and lower energetic cost of Glf [22]. In addition, C4-
dicarboxylic acid transporter genes were also activated to
decrease the feedback effects through accelerating succinate
export [23, 24].
Although considerable metabolic targets are available to
improve succinate production, genes involved in compet-
ing pathways such as the formation of lactate, acetate, for-
mate and ethanol were inactivated in previous works. In
this study, targeted engineering strategy was employed to
optimize metabolic pathway of succinate production from
glucose without deletions of ldhA, pflB, pta-ackA, and
adhE (Fig. 1). Focusing on PEP node as the engineering
target, metabolic flux from PEP was enhanced to OAA
and minimized to lactate and acetate. By pentuple dele-
tions of genes ptsG (coding glucose phosphotransferase),
pykA (coding pyruvate kinase II), ppc, maeA and maeB
(coding malic enzymes) of the central carbon metabolism,
we reconstructed initial E. coli strain to increase PEP pool
for succinate production. Then we optimized metabolic
flux to succinate from PEP by deletion of sdh (coding
succinate dehydrogenase) and iclR (coding transcriptional
repressor IclR) as well as co-overexpression of pck-ecaA
(coding carbonic anhydrase). We further attenuated the
accumulation of lactate and acetate by fine tuning of pykF
(coding pyruvate kinase I) expression via antisense sRNA
strategy to prevent metabolic flux to pyruvate from PEP.
Finally, the fermentation process was carried out with op-
timized succinate-producing strains.
Results and discussion
Initial construction for succinate production
The wildtype E. coli BW25113 (DE3) produced a small
amount of succinate in the acid mixture (Fig. 2) from glu-
cose under anaerobic fermentation conditions, which was
consistent with the previous report [6]. Glucose uptake
through PTS system consumes almost half of the available
PEP that is the precursor of succinate, which leads to the
significantly decreased amounts of PEP for succinate pro-
duction. In E. coli, the inactivation and mutation of genes
involved in the PTS system was beneficial for succinate
production [25, 26]. Thus, to save PEP from consumption
of PTS system, we deleted ptsG gene in strain BW25113
(DE3) and constructed strain BKS4. Succinate production
of strain BKS4 was significantly increased with 2.0-fold
higher yield than that of strain BW25113 (DE3) (p < 0.01)
(Fig. 2). Meanwhile, the yields of lactate and acetate in
strain BKS4 were decreased by 17.65 % (p < 0.05) and
19.83 % (p < 0.01), respectively. The results indicated that
the inactivation of PTS system played an essential role in
the availability of PEP to support succinate production.
In succinate metabolic pathway, the carboxylation of PEP
catalyzed by PPC or PCK is a rate-limiting step committed
to succinate production. ATP is essentially consumed for
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PPC catalyzing the formation of OAA from PEP [27]. On
the contrary, one molecule ATP is generated from carb-
oxylation of one molecule PEP catalyzed by PCK. The dele-
tion of pck gene in E. coli remarkably inhibited succinate
production as well as the cell growth [27], indicating that
PCK might be more efficient than PPC. In addition, the
function of PCK was partially inhibited by PPC under an-
aerobic fermentation [13, 14]. Thus, we deleted ppc gene to
enhance energy supplement and activate PCK. Further-
more, both PEP and malate would convert to pyruvate,
which is smoothly turned into byproducts lactate, acetate
and formate via the decarboxylation, dehydrogenation, and
pyruvate-formate lyase, respectively. Formate is further split
into carbon dioxide and water by formate dehydrogenase,
while lactate and acetate accumulate in fermentation broth.
Since the substrate specificity of malic enzymes for malate
is 6-fold higher than that for pyruvate, malic enzymes
encoded by maeA and maeB tend to catalyze the decarb-
oxylation of malate to pyruvate [28]. The formation of
pyruvate and its derivative byproducts strongly compete
with succinate production for PEP and malate. Inactivation
of pykA and pykF has been shown to be effective in inhibit-
ing the conversion of PEP to pyruvate [29]. Consequently,
in order to inhibit the formation of pyruvate from PEP and
Fig. 1 Targeted engineering of the central carbon metabolism for succinate production in E. coli. Red crosses represent deletion of gene and the
reactions affected by the deletion are indicated with grey. The black arrows of the reactions involved in the overexpressed genes are thickened. Red
┫ represents inhibition of pykF expression by anti-pykF sRNA either on high-copy-number plasmid (pRSFDuet-1) (H) or low-copy-number plasmid
(pBldgbrick2) (L). Genes coding the corresponding enzymes in the pathways: ptsG, glucose phosphotransferase; pykF, pyruvate kinase I; pykA, pyruvate
kinase II; ppc, PEP carboxylase; pck, PEP carboxykinase; ecaA, carbonic anhydrase; iclR, transcriptional repressor IclR; aceA, isocitrate lyase; aceB, malate
synthase; aceK, isocitrate dehydrogenase kinase/phosphatase; ldhA, lactate dehydrogenase; pflB, pyruvate formate lyase; pdh, pyruvate dehydrogenase;
poxB, pyruvate oxidase; pta, phosphotransacetylase; ackA, acetate kinase; adhE, alcohol/acetaldehyde dehydrogenase; maeAB, malic enzyme; mdh,
malate dehydrogenase; fumABC, fumaraseABC; frd, fumarate reductase; sdh, succinate dehydrogenase; sucABCD, succinyl CoA synthase; icd, isocitrate
dehydrogenase; acnAB, aconitate hydratase; gltA, citrate synthase
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malate, we deleted pykA, maeA and maeB genes. Unfortu-
nately, compared to strain BKS4, strain BKS8 with deletion
of pykA, ppc, maeA and maeB did neither significantly
attenuate the accumulation of lactate and acetate, nor in-
crease the succinate yield (Fig. 2). The low expression level
of pck gene in wild-type E. coli could result in the insuffi-
cient metabolic flux to OAA [27], and pykF might be more
active than pykA in the formation of pyruvate from PEP. It
suggested that pck and pykF genes could be the potential
targets. Therefore, using initial strain BKS8, we further
optimize these two targets of succinate metabolic pathway
to improve succinate production.
Combined optimization of targeting at TCA cycle and
carboxylation of PEP to increase succinate production
Succinate, an essential intermediate of TCA cycle, cannot
be efficiently accumulated in E. coli fermentation. In order
to increase succinate production, we optimized succinate
metabolic pathway by preventing the backflow of succinate
to fumarate, activating glyoxylate shunt bypass to decrease
the requirement of reducing power, and co-overexpressing
pck-ecaA to fix CO2 more efficiently.
Succinate dehydrogenase (SHD) encoded by sdh gene cat-
alyzes the dehydrogenation of succinate to fumarate. The
sdh expression was not totally inhibited under anaerobic
conditions [30]. Herein, we deleted sdh gene to enhance the
reductive TCA arm and block the conversion of succinate
to fumarate in strain BKS8 background. As expected, the
titer and yield of succinate in strain BKS9 were increased by
55.24 % (7.11 mM) (p < 0.05) and 50.00 % (0.33 mol/mol
glucose) (p < 0.05), respectively (Fig. 3). The inactivation of
sdh gene showed to increase succinate production in E. coli
and Corynebacterium glutamicum under aerobic conditions
[31–33]. To the best of our knowledge, sdh gene was first
deleted to improve anaerobic succinate production in our
study.
Glyoxylate shunt bypass could recover the metabolic flux
of the oxidative TCA arm and acetyl-CoA of pyruvate me-
tabolism with less reducing power used, and might contrib-
ute to succinate production. The aceBAK operon coding
isocitrate lyase, malate synthase and isocitrate dehydrogen-
ase kinase is responsible for the glyoxylate shunt bypass.
The transcription of the aceBAK operon is tightly repressed
by transcription factor IclR, but induced by inactivating iclR
gene [34]. Thus, the deletion of iclR gene resulted in strain
BKS10. As shown in Fig. 3, the titer and yield of succinate
in strain BKS10 was not apparently increased. It was likely
that the gene expression involved in glyoxylate bypass are
complex and regulated by multiple factors [35] and deletion
of iclR was not sufficient for activating glyoxylate shunt
bypass [36]. Conversion of PEP to OAA in succinate meta-
bolic pathway is net carbon integrated via CO2 fixation
catalyzed by PCK. In fact, the active substrate for PCK is
not CO2, but the chemically less reactive bicarbonate anion
(HCO3
−) [37]. Thus, CaCO3, MgCO3 or NaHCO3 were
often added to the culture media. CO2 is more permeable
Fig. 2 Yields of succinate, lactate and acetate of initial succinate-producing strains. Error bars represent SD for three replicates. Asterisks indicate
p-values (**p < 0.01, *p < 0.05) compared to BW25113 (DE3)
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across cell membrane than HCO3
−, but the hydration reac-
tion rate of CO2 to HCO3
− is relatively slow. There might
not be enough HCO3
− spontaneously made in vivo to access
succinate production. Carbonic anhydrase encoded by ecaA
gene catalyzes the hydration of intracellular CO2 to HCO3
−.
Expression of ecaA gene of cyanobacterium Anabaena in
E. coli led to an obvious increase in succinate production
[38, 39]. Thus, the ecaA gene was co-expressed with pck in
strain BKS10, generating strain BKS11. Compared to strain
BKS10, combinatorial expression of pck-ecaA in strain
BKS11 resulted in a 2.2-fold increase in succinate yield
(1.16 mol/mol glucose) (p < 0.01) and a 1.2-fold increase in
succinate titer (18.17 mM) (p < 0.01) (Fig. 3).
Fine tuning of pykF expression to improve succinate
production
Although succinate production was increased remarkably
in engineered strains, the yields and titers of lactate and
acetate remained high by using the strategies aforemen-
tioned in the text (Fig. 4b, c, d), which suggested that meta-
bolic flux from PEP to pyruvate was relatively strong.
Deletion of maeA and maeB and pykA did not significantly
attenuated the accumulation of lactate and acetate (Fig. 2),
suggesting that pykF gene might dominate the formation of
pyruvate. Thus the strategy of synthetic small RNA (sRNA)
engineering [40] was used to finely tune the expression of
pykF to attenuate the accumulation of lactate and acetate.
Using AUG to nucleotide +24 of the pykF mRNA as
the binding sequence and selecting E. coli micC as the
scaffold, anti-pykF sRNA working sequence was de-
signed (Fig. 4a). We used two kinds of plasmids with
different copy number and tested the inhibitory effects
of anti-pykF sRNA on the accumulation of lactate and
acetate in strain BKS12 with overexpression of pck gene.
When anti-pykF sRNA was expressed on the high-copy-
number plasmid pRSF and under the control of T7 pro-
moter, no obvious changes were observed in the yields
of succinate, lactate and acetate (Fig. 4b). Then, we con-
structed the low-copy-number plasmid pBldg-anti-pykF
with a pY15A origin of replication, and expression of
anti-pykF was controlled under lacUV5 promoter. The
metabolite analysis of engineered strain BKS14 showed
that the yields of lactate and acetate were decreased by
55.77 % (p < 0.01) and 47.73 % (p < 0.01), respectively,
Fig. 3 Deletion of sdh and iclR, and co-overexpression of pck-ecaA increased succinate production. Error bars represent SD for three replicates. Asterisks
indicate p-values (**p < 0.01, *p < 0.05) in which BKS9 and BKS10 were compared to BKS8 and BKS11 was compared to BKS10
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and the yield of succinate was increased by 23.38 %
(p < 0.05) compared to BKS12(Fig 4b).
We further tested whether the expression of anti-pykF
under the control of lacUV5 promoter in strain BKS11
would improve succinate production and attenuate accu-
mulation of byproducts. pBldg-anti-pykF was transformed
into strain BKS11, generating strain BKS15. Compared to
strain BKS11, the low expression of anti-pykF in strain
BKS15 led to the decrease of 43.48 % (p < 0.05) and
38.09 % (p < 0.01) in the yields of lactate and acetate, re-
spectively (Fig 4c). Although succinate yield of strain
BKS15 was not improved, succinate titer was increased by
13.43 % (p < 0.05) (Fig. 4d). The results showed that the
down-regulated formation of pyruvate by expressing anti-
Fig. 4 Fine tuning of pykF expression strength to improve succinate production and attenuate accumulation of lactate and acetate. a Two anti-pykF
sRNA plasmids were designed and constructed at different expression levels by combinations of promoters and plasmid copy number. (H) and (L)
represented high-copy-number plasmid (pRSF) and low-copy-number plasmid (pBldgbrick2), respectively. b Relative yields of succinate, lactate and
acetate. BKS12 was compared to BKS8 and BKS13 and BKS14 were compared to BKS12. c Yields of succinate, lactate and acetate. The significance was
compared to BKS11. d Titers of succinate, lactate and acetate. The significance was compared to BKS11. Error bars represent SD for three replicates.
Asterisks indicate p-values (**p < 0.01, *p < 0.05)
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pykF would enhance the metabolic flux from PEP to
succinate.
Distribution of intracellular metabolic flux
Genetic and metabolic modification used in this study
remarkably increased succinate production and attenuated
the accumulation of lactate and acetate. However, the intra-
cellular metabolic flux distribution of the metabolic net-
work was still unclear. In order to demonstrate in detail
how previous efforts changed the metabolic flux directions
and optimized the performance of succinate-producing
strains step by step, global metabolic flux analysis was
made. The simplified metabolic model that described the
metabolic relationship in anaerobically fermentative E. coli
was shown in Fig. 5. This model was comprised of fifteen
intermediates and sixteen metabolic reactions designated
by V1-V16 (Additional file 1: Table S1). Among these six-
teen reactions, the measurable quantities V1, V6, V16 and
(V7 +V10) were used to calculate the metabolic fluxes of
other intermediates according to relationships shown in
Additional file 1: Table S2. The estimated metabolic fluxes
in mM gDCW−1 h−1 of E. coli stains BW25113(DE3),
BKS8, BKS9, BKS10, BKS11 and BKS15 under anaerobic
fermentation were presented in Additional file 1: Table S3.
As shown in Fig. 5, metabolic modifications led to the
fact that fluxes to OAA (V5), malate (V12), fumarate
(V13), succinate (V15 and V16) were significantly in-
creased and that fluxes to pyruvate (V4), lactate (V6),
and acetate (V7 + V10) were remarkably decreased from
strains BW25113(DE3) to BKS15. The results indicated
that our strategies favored the improvement of succinate
production and the decrease of byproduct accumulation.
The split ratios of fluxes to OAA, PYR, lactate, acetate
and succinate were obtained by analyzing the PEP, PYR,
acetyl-CoA and succinate nodes. As shown in Table 1,
compared to strain BW25113 (DE3), the fraction of the
metabolic flux diverted to OAA from PEP node (V5/V3) in
strain BKS8 increased by 1.8-fold (p < 0.01), corresponding
2.2-fold fraction increase of the metabolic flux to succinate
(V16/V3) (p < 0.01). Pentuple deletions of ptsG, ppc, pykA,
maeA and maeB could significantly streamline PEP pool
for succinate production. Strain BKS9 showed the increase
of the metabolic flux to succinate (V16/V3), indicating the
deletion of sdh gene resulted in more metabolic flux to
Fig. 5 Metabolic flux analysis of succinate-producing strains. The fluxes in mM gDCW−1 h−1 were calculated according to fermentation data at 40 h
and normalized by glucose consumption rate as well as expressed in a basis of 100
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OAA from PEP node (V5/V3). Strain BKS10 did not show
carbon flux through glyoxylate shunt bypass (V11 = 0) in
the stoichiometric model, indicating that deletion of iclR
gene did not activate glyoxylate shunt bypass.
In strain BKS11, 45.94 % of PEP was converted to OAA
(V5/V3), 2.4-fold higher than that of strain BKS10 (p <
0.01). As a result, the fraction of the metabolic flux to suc-
cinate (V16/V3) increased from 13.66 % in strain BKS10
to 55.54 % in strain BKS11 (Table 1) (p < 0.01). Meanwhile,
strain BKS11 showed lower acetic fluxes ((V7 + V10)/V3).
This indicated that co-overexpression of pck-ecaA could
significantly enhanced the metabolic flux of PEP to OAA,
and simultaneously inhibit other metabolic branches.
Compared to strain BKS11, the fractions of the metabolic
flux to lactate (V6/V3) and acetate ((V7 + V10)/V3) of
strain BKS15 decreased by 12.32 % (p < 0.05) and 18.94 %
(p < 0.01), respectively (Table 1), indicating that expression
of anti-pykF attenuated the accumulation of lactate and
acetate. At last, with a series of metabolic modifications,
compared to strain BW25113(DE3), the final fraction of
the metabolic flux to succinate in BKS15 was increased by
24.8 fold (p < 0.01) and those to lactate and acetate were
decreased by 36.57 % (p < 0.01) and 61.28 % (p < 0.01),
respectively.
Anaerobic batch fermentation for succinate production
To estimate the fermentation behaviors of engineered
succinate-producing strains, anaerobic batch experiments
were conducted. The titers, yields , specific productivities
and productivities of succinate, lactate and acetate in 70 h
fermentation were summarized in Table 2. As shown in
Fig. 6, the distribution pattern of glucose metabolism and
the production of succinate, lactate and acetate were re-
markably changed. Strain BKS10 exhausted almost glu-
cose, and accumulated large amounts of lactate and
acetate, and a small amount of succinate in 70 h fermenta-
tion. Compared to strian BKS10, co-overexpression of pck-
ecaA in strain BKS11 retarded glucose consumption, but
achieved higher succinate production (25.51 mM), higher
succinate yield (0.92 mol/mol glucose) and higher succin-
ate specific productivity (3.96 mmol gDCW−1 h−1), in-
creased by 1.9- (p < 0.01), 1.9- (p < 0.01) and 2.6-fold (p <
0.01), respectively. Moreover, the accumulation of lactate
and acetate was significantly attenuated. When anti-pykF
was further expressed in strain BKS15, glucose was com-
pletely consumed and largely distributed to succinate. Pro-
duction of succinate in strain BKS15 was increased at a
linear manner during the fermentation, and the specific
productivity of succinate increased by 48.74 % (p < 0.01);
the accumulation of acetate was greatly decreased, and the
specific productivity of acetate decreased by 31.64 % (p <
0.01). Engineered strain BKS15 showed the optimal fer-
mentation performance of higher productivity, titer and
yield of succinate with the lower accumulation of lactate
and acetate.
Conclusion
In this paper, PEP was selected as optimized target for in-
creased succinate production and attenuated accumulation
of byproducts in engineered E. coli under anaerobic condi-
tions. By deleting ptsG, pykA, ppc and maeAB genes, we
have designed and constructed initial succinate-producing
E. coli strain. The succinate metabolic pathway was then
enhanced with deletion of sdh and co-overexpression of
pck-ecaA, resulting in succinate production of 25.51 mM.
By introducing artificial sRNA of anti-pykF, the titer of suc-
cinate in the final optimized strain BKS15 was 30.12 mM
with remarkable decrease in lactate and acetate. Metabolic
flux analysis and fermentation kinetics showed that our
optimization strategy could efficiently enhance the central
carbon flux to succinate and decrease to byproducts. Re-
cently, the progress in metabolic engineering suggested that
limitation of cellular ATP supply and redox unbalance
can be alleviated for improving succinate production in
E. coli [41]. Combination of our strategies with those
targets would further develop high succinate-producing
microorganisms.
Methods
Bacterial strains and plasmids
E. coli DH5α was used for plasmids cloning and BW25113
was used as the wildtype strain for the construction of all
engineered strains described in this study and succinate
production. The ecaA gene was kindly donated by professor
Jian-Min Xing, Chinese Academy of Sciences. Bacterial
Table 1 Split ratios of fluxes to OAA, PYR, lactate, acetate and succinate







production (V7 + V10)/V3
Fraction of succinate
production (V16/V3)
BW25113(DE3) 3.08 ± 0.02 % 96.92 ± 0.02 % 23.46 ± 0.71 % 77.25 ± 2.66 % 2.61 ± 0.02 %
BKS8 8.53 ± 0.03 % 91.47 ± 0.02 % 19.43 ± 0.48 % 73.70 ± 1.56 % 8.29 ± 0.01 %
BKS9 12.39 ± 0.45 % 86.93 ± 1.43 % 19.95 ± 0.14 % 66.74 ± 0.08 % 12.61 ± 0.47 %
BKS10 13.66 ± 0.22 % 86.34 ± 1.10 % 18.28 ± 0.44 % 67.84 ± 2.89 % 13.66 ± 0.22 %
BKS11 45.94 ± 0.73 % 53.87 ± 0.72 % 16.97 ± 0.59 % 36.90 ± 0.32 % 55.54 ± 0.98 %
BKS15 52.31 ± 0.83 % 47.69 ± 0.67 % 14.88 ± 0.76 % 29.91 ± 0.70 % 67.20 ± 0.78 %
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Table 2 Parameters of succinate production by engineered E. coli strians during anaerobic fermentation
Strains Growth
rate (h−1)
Titer (mM) Yield (mol/mol of glucose) Specific productivity (mmol gDCW−1 h−1) Productivity (mmol L−1 h−1)
Succinate Lactate Acetate Succinate Lactate Acetate Succinate Lactate Acetate Succinate Lactate Acetate
BKS10 0.071 ± 0.002 8.65 ± 0.73 12.06 ± 0.70 27.13 ± 2.56 0.31 ± 0.02 0.43 ± 0.02 0.98 ± 0.09 1.09 ± 0.06 1.47 ± 0.20 3.31 ± 0.13 0.12 ± 0.01 0.17 ± 0.01 0.39 ± 0.04
BKS11 0.052 ± 0.003** 25.51 ± 1.79** 7.82 ± 0.63** 23.52 ± 1.53 0.92 ± 0.06** 0.28 ± 0.02** 0.85 ± 0.05 3.96 ± 0.13** 1.18 ± 0.04* 3.54 ± 0.08 0.36 ± 0.03** 0.11 ± 0.01 0.34 ± 0.02
BKS15 0.043 ± 0.002* 30.12 ± 3.31 6.55 ± 0.33* 13.22 ± 1.64** 1.08 ± 0.11 0.24 ± 0.01* 0.48 ± 0.06** 5.89 ± 0.41** 1.20 ± 0.07 2.42 ± 0.19** 0.43 ± 0.05 0.09 ± 0.01 0.19 ± 0.02**











strains and plasmids used in this study were listed in
Table 3.
Construction of engineered strains and plasmids
Restriction endonucleases and T4 DNA ligase were pur-
chased from Thermo Scientific (USA), High-Fidelity DNA
polymerase used for PCR amplification was purchased from
Transgene Biotech (Beijing, China). Appropriate restriction
sites were added to 5′and 3′ ends of the primers and all
primers used in this study were listed in Additional file 1:
Table S4. All plasmids was constructed through the enzym-
atic digestion of PCR products and plasmids with appropri-
ate restriction sites, followed by the ligation of the
appropriate fragments. Clones bearing inserted gene were
screened by PCR and recombinant plasmids were con-
firmed by DNA sequencing.
By using the lambda Red recombinase system [42], the
gene coding for T7 RNA polymerase was inserted into the
genome of E. coli BW25113. The DNA fragment containing
500 bp upstream of the ybhB gene, T7 RNA polymerase
gene, chloramphenicol resistance cassette and 500 bp
downstream of the ybhC gene was constructed. The de-
tailed procedure was shown in Additional file 1: Figure S1
and the primers used were shown in Additional file 1: Table
S4. This DNA fragment was then electrotransformed into
E. coli BW25113 which expressed lambda Red system for
homologous recombination. The positive clones were con-
firmed with primers F-ybhB and R-ybhC. Next, the chlor-
amphenicol resistance cassette was removed with the help
of pCP20 and its removal was confirmed with primers F-
ybhB and R-ybhC. The function of T7 RNA polymerase in
BW25113 (DE3) was verified by SDS-PAGE of BW25113
(DE3) carrying pCDF-pck, using BL21 (DE3) harboring
pCDF-pck and BW25113 harboring pCDF-pck as posi-
tive and negative controls, respectively (Additional file
1: Figure S2).
All in-frame gene deletion strains were constructed in E.
coli BW25113 (DE3) according to the procedure described
previously [42] and confirmed by PCR. Briefly, for deleting
ptsG as example, the DNA fragment containing the chlor-
amphenicol resistance cassette for homologous recombin-
ation was amplified by PCR using F-ptsG-Q and R-ptsG-Q
as primers and the plasmid pKD3 as the template. The
DNA fragment was then electrotransformed into E. coli
BW25113 (DE3) which expressed lambda Red system for
homologous recombination. The replacement of ptsG gene
was confirmed by PCR using the primers F-ptsG and R-
ptsG and the removal of chloramphenicol resistance was
confirmed with primers F-ptsG and R-ptsG listed in
Additional file 1: Table S4. The same procedure was per-
formed for deletions of pykA, ppc, maeA, maeB, sdh, and
iclR.
For construction of pRSF-anti-pykF and pBldg-anti-
pykF, the complementary sequence that spans to + 24
nucleotides of pykF coding mRNA was used as the bind-
ing sequence and was designed in the primer. In order to
construct pRSF-anti-pykF, the sequence between RBS and
terminator was removed from pRSFDuet-1 using primers
F-RSF and R-RSF, followed by the ligation, resulting in
pRSFM1. The scaffold micC with 24 bp binging sequence
at the 5′ end [40] was amplified with primers F-RSF-anti-
pykF and R-RSF-anti-pykF and cloned into the SpeI site of
Fig. 6 Anaerobic fermentation of engineered succinate-producing
strains. a BKS10, b BKS11, c BKS15
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pRSFM1 (high-copy-number plasmid), and resulting in
plasmid pRSF-anti-pykF. The correct construct pRSF-
anti-pykF was screened by PCR using primers ACYC-
DuetUP1 and R-RSF-anti-pykF, and confirmed DNA se-
quencing. The DNA fragment containing 24 bp binding
sequence and micC was amplified by PCR with primers F-
Bldg-anti-pykF and R-Bldg-anti-pykF listed in Additional
file 1: Table S4 using E. coli BW25113 genome as tem-
plate. Then, PCR product was cloned into vector
pBldgbrick2 (low-copy-number plasmid) [43] between
HindIII and NcoI, resulting plasmid pBldg-anti-pykF. The
plasmids with anti-pykF sequence were used to silence the
expression of pykF gene.
Fermentation conditions
Dual phase fermentation mode was employed [38]. For all
engineered E. coli strains, a seed inoculum of 500 μL from
an overnight 3 mL of LB culture was first inoculated at
37 °C in 250 mL shake flask containing 100 mL of liquid
LB medium for aerobic growth. When the optical density
(OD) reached 1.0, cells were induced with a final concen-
tration of 0.1 mM isopropyl-β-D-thiogalactopyranoside
(IPTG) and grown for another 3 h for recombinant pro-
tein expression. Then, bacterial cells were collected by
centrifugation and resuspended in 150 mL shake flask
containing 100 mL of fresh YM9 medium (1*M9 salts,
1 g/L yeast extract) at an initial OD of 1.0 for anaerobic
Table 3 E. coli strains and plasmids used in this study
Name Characteristics Source
Strains
BW25113 lacIqrrnBT14ΔlacZWJ16hsdR514ΔaraBADAH33 NBRP-E. coli at NIG
BW25113(DE3) lacIqrrnBT14ΔlacZWJ16hsdR514ΔaraBADAH33dcm (DE3) This study
BKS1 BW25113(DE3) harboring pCDF-pck This study
BKS2 BW25113 harboring pCDF-pck This study
BKS3 BL21(DE3) harboring pCDF-pck This study
BKS4 BW25113(DE3) ΔptsG::FRT This study
BKS5 BKS4 ΔpykA::FRT This study
BKS6 BKS5 Δppc::FRT This study
BKS7 BKS6 ΔmaeA::FRT This study
BKS8 BKS7 ΔmaeB::FRT This study
BKS9 BKS8 Δsdh::FRT This study
BKS10 BKS9 ΔiclR::FRT This study
BKS11 BKS10 harboring pCDF-pck-ecaA This study
BKS12 BKS8 harboring pCDF-pck This study
BKS13 BKS8 harboring pCDF-pck and pRSF-anti-pykF This study
BKS14 BKS8 harboring pCDF-pck and pBldg-anti-pykF This study
BKS15 BKS11 harboring pBldg-anti-pykF This study
Plasmids
pKD3 FRT(FLP recognition target) sites; CmR (Datsenko and Wanner 2000)
pKD46 Red recombinase expression vector; AmpR (Datsenko and Wanner 2000)
pCP20 FLP expression vector; AmpR,CmR (Datsenko and Wanner 2000)
pETDuet-1 pBR322 ori with PT7; Amp
R Novagen
pCDFDuet-1 CDF ori with PT7; Str
R Novagen
pRSFDuet-1 RSF ori with PT7; Kan
R Novagen
pBldgbrick2 p15A ori with PlacUV5; Cm
R (Yao et al, 2013)
pCDF-pck pCDFDute-1 with pck This study
pCDF-pck-ecaA pCDFDuet-1 with pck and ecaA This study
pRSFM1 pRSF without RBS sequence This study
pRSF-anti-pykF pRSFM1 with anti-pykF This study
pBldg-anti-pykF pBldgbrick2 with anti-pykF This study
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fermentation. At that point, 5 g/L CaCO3, 2 g/L NaHCO3,
0.1 mM IPTG were added. Flasks were sealed with non-
ventilated plugs. The cells were incubated at 37 °C on a
shaker (150 rpm) and sample were collected at 40 h for
analysis. For kinetic study, samples were collected at 0, 8,
16, 24, 34, 46, 58 and 70 h. Appropriate amounts of antibi-
otics (50 mg/L ampicillin, 30 mg/L streptomycin, 30 mg/L
kanamycin) were added to media when needed.
Analytical techniques
Cell growth was monitored by measuring the optical dens-
ity (OD) at 600 nm (UV-vis spectrophotometer) and was
transformed into dry cell weight using the coefficient as:
dry cell mass (g L−1) = 0.48*OD600 [44]. The concentration
of glucose was measured using SBA-90B biosensor (Biol-
ogy Institute of ShanDong Academy of Science, China).
The sample was centrifuged and the supernatant of fer-
mentation sample was filtered through 0.2 μm syringe filter
and metabolites were analyzed using an Waters 1515
differential HPLC system equipped with a Bio-Red HPX-
87H HPLC column. 10 μL of sample was injected into the
HPLC at column temperature of 65 °C and ran isocratically
with 5 mM H2SO4 as mobile phase sat on a flow rate of
0.6 ml/min.
Metabolic flux analysis
The metabolic network was constructed based on engi-
neered pathways in anaerobically grown E. coli (Fig. 1).
This network included glycolysis, TCA cycle and glyox-
ylate bypass (Fig. 5). As an attempt to analyze the dis-
tribution of carbon source, the fluxes through each
pathway in the metabolic network were designated by
V1-V16. The simplified central metabolic reactions
were described in detail in Additional file 1: Table S1.
According to the law of mass conversation and the
quasi-steady-state assumption, these metabolic flux re-
lationships were constructed to simplify the computa-
tional process, and shown in Additional file 1: Table S2,
in which V1, V6, V16, and V7 + V10 were measurable
quantities while the others were the metabolic fluxes of
the corresponding intermediates. In this study, Lingo
software [45] was used to obtain the solutions to distri-
bution of metabolic fluxes that were limited by the for-
mulas in Additional file 1: Table S2.
Statistical analysis
The data are shown as mean values ± standard deviation
(SD) of three replicates. The Student’s t test was used for all
statistical analysis using SPSS 17.0. The p-value of < 0.05
and < 0.01 was considered statistically significant, more sig-
nificant, respectively.
Additional file
Additional file 1: Figure S1. Assembly of DNA fragment for inserting the
T7 RNA polymerase into BW25113 genome. Figure S2. SDS-PAGE of protein
expression of strain BKS1, BKS2 and BKS3. Table S1. The simplified central
metabolic reaction of engineered E. coli anaerobically grown in glucose.
Table S2. Stoichiometric relationships for fluxes of metabolic reactions in
anaerobic growth of E. coli. Table S3. Metabolic fluxes (mM gDCW−1 h−1)
of engineered strains based on the anaerobic fermentation results at 40 h.
Table S4. Primers used in this study. (DOCX 128 kb)
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